Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for NDAs filing: Malvern, Pennsylvania Thursday, October 17, 2024, 18:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you